|
|
|
|
C-006 / C-006-1ML updated item number format
Codeine
1.0 mg/mL in Methanol | Certified Reference Material
|
|
Codeine is an opiate used for its analgesic, antitussive, and sedative properties and is the second-most predominant alkaloid in opium. This certified reference solution is suitable for use as a starting material in calibrators and controls for LC/MS and GC/MS testing methods in clinical toxicology, forensic analysis, pharmaceutical research, and pain prescription monitoring. As a widely popular recreational drug, codeine is regulated under various narcotic control laws in countries such as Australia, New Zealand, Romania, Sweden, and the United States. Since opiates are classified as controlled substances, Cerilliant offers most opiate reference standards as DEA-exempt solutions for added convenience.
|
|
|
|
|
| Concentration:
|
1.0 mg/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
76-57-3
|
| Chemical Formula:
|
C18H21NO3
|
| Molecular Weight:
|
299.36
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| A-053 / A-053-1ML |
|
6-Acetylcodeine, 1.0 mg/mL
|
|
$62.10
|
|
|
|
|
|
| C-005 / C-005-1ML |
|
Codeine-D3, 100 μg/mL
|
|
$40.00
|
|
|
|
|
|
| C-007 / C-007-1ML |
|
Codeine-D3, 1.0 mg/mL
|
|
$153.00
|
|
|
|
|
|
| C-015 / C-015-1ML |
|
Codeine, 100 μg/mL
|
|
$32.50
|
|
|
|
|
|
| C-040 / C-040-1ML |
|
Codeine-D6, 100 μg/mL
|
|
$43.30
|
|
|
|
|
|
| C-041 / C-041-1ML |
|
Codeine-D6, 1.0 mg/mL
|
|
$172.00
|
|
|
|
|
|
| C-087 / C-087-1ML |
|
Codeine-6-β-D-glucuronide, 100 μg/mL
|
|
$177.00
|
|
|
|
|
|
| C-126 / C-126-1ML |
|
Codeine-6β-D-glucuronide, 1.0 mg/mL
|
|
$441.00
|
|
|
|
|
|
| C-138 / C-138-1ML |
|
Codeine-6-ß-D-glucuronide-D3, 100 µg/mL
|
|
$191.00
|
|
|
|
|
|
| D-019 / D-019-1ML |
|
Dihydrocodeine HCl, 1.0 mg/mL (as free base)
|
|
$27.70
|
|
|
|
|
|
| D-021 / D-021-1ML |
|
Dihydrocodeine-D6 HCl, 100 μg/mL (as free base)
|
|
$38.40
|
|
|
|
|
|
| D-087 / D-087-1ML |
|
Dihydrocodeine-D6 HCl, 1.0 mg/mL (as free base)
|
|
$389.00
|
|
|
|
|
|
| N-005 / N-005-1ML |
|
Norcodeine, 1.0 mg/mL
|
|
$43.00
|
|
|
|
|
|
| O-020 / O-020-1ML |
|
Opiate Multi-Component Mixture-5, 250 μg/mL of each component
|
|
$164.00
|
|
|
|
|
|
| P-071 / P-071-1ML |
|
Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl
|
|
$441.00
|
|
|
|
|
|
| T-116 / T-116-1ML |
|
Thebaine, 1.0 mg/mL
|
|
$75.50
|
|
|
|
|
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1077 - no Health Canada import authorization required
read more about ordering regulated substances
Methods
method 1694
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
|
▶ Advanced Toxicology Testing for Compounds using Core-Shell Technology | Erica A. Guice, Jessica Marsh, Seyed Sajadi, and Matthew Pentis, Western Slope Laboratory, 2012
|
|
▶ An Automated Solid Phase Extraction Method for Opiates in Urine | Jeffery Hackett and Michael Telepchak, UCT, Inc., 2012
|
|
▶ Comparison of Forensic Tandem Mass Spectral Data Obtained on Portable Instrumentation to an Established Reference Library | Adam E. O’Leary, Seth E. Hall, Herbert M. Oberacher, andChristopher C. Mulligan, llinois State University Department of Chemistry, 2014
|
|
▶ Development of a high-throughput LC-MS/MS assay for pain management panel from urine | Hui Qiao, Changtong Hao, Sha Joshua Ye, Lisa Cousins, IONICS Mass Spectrometry Group inc., 2014
|
|
▶ Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
|
|
▶ Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
|
|
▶ LC-MS (TOF) Analysis of Opioids and Opiate-Dependence Management Drugs on Ascentis® Express HILIC | Sigma-Aldrich®, 2014
|
|
▶ LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
|
|
▶ LC/MS/MS Analysis of Drugs of Abuse: Generic Screening on Ascentis® Express F5 | Sigma-Aldrich®, 2015
|
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
▶ Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014
|
|
▶ Rapid Differentiation of Isobaric Drugs Using a Novel Direct Sample Analysis Source, CID, and Accurate Mass TOF Mass Spectrometry | Robert J. Seward, Bonnie Marmor, and Andrew Tyler, PerkinElmer, Inc., 2014
|
|
▶ Testing and Quantification of a Representative Panel of Illicit Drugs in Urine and Serum Using LC-Time-of-Flight Mass Spectrometry | Avinash Dalmia, Noelle M. Elliott, Joanne Mather, Bonnie Marmor, George Perkins;, PerkinElmer, Inc., 2014
|
|
▶ Testing and Quantitation of Opioids in Urine and Serum by LC-TOF | Sharanya Reddy, Nonnie Danna, PerkinElmer Inc,, 2014
|
|
▶ UHPLC/MS Analysis of Heroin and Related Compounds on Titan™ C18 | Sigma-Aldrich®, 2015
|
|
▶ Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine following Optimized Enzymatic Hydrolysis Conditions | Sigma-Aldrich®, 2015
|
|
|
|
|